<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.4.0.13 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/13/2023 11:29:28 AM-->
<!--Modified on: 11/13/2023 11:29:28 AM-->
<xsd:schema targetNamespace="http://www.aeonbiopharma.com/20230930" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:srt="http://fasb.org/srt/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:attributeFormDefault="unqualified" xmlns:srt-roles="http://fasb.org/srt-roles/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:aeon="http://www.aeonbiopharma.com/20230930">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/StatementCondensedConsolidatedBalanceSheets" id="StatementCondensedConsolidatedBalanceSheets">
        <link:definition>00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" id="StatementCondensedConsolidatedStatementsOfCashFlows">
        <link:definition>00400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails">
        <link:definition>40202 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureForwardMergerSummaryOfPurchasePriceCalculationDetails" id="DisclosureForwardMergerSummaryOfPurchasePriceCalculationDetails">
        <link:definition>40302 - Disclosure - Forward Merger - Summary of the purchase price calculation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingenciesSupplementalBalanceSheetInformationRelatedToOperatingLeaseDetails" id="DisclosureCommitmentsAndContingenciesSupplementalBalanceSheetInformationRelatedToOperatingLeaseDetails">
        <link:definition>40702 - Disclosure - Commitments and Contingencies - Supplemental balance sheet information related to the operating lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DocumentCommitmentsAndContingenciesSupplementalBalanceSheetInformationRelatedToOperatingLeaseDetailsCalc2" id="DocumentCommitmentsAndContingenciesSupplementalBalanceSheetInformationRelatedToOperatingLeaseDetailsCalc2">
        <link:definition>40702 - Document - Commitments and Contingencies - Supplemental balance sheet information related to the operating lease (Details) - Calc2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersDeficit" id="StatementCondensedConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersDeficit">
        <link:definition>00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsTables" id="DisclosureFairValueMeasurementsTables">
        <link:definition>30603 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureShareBasedCompensationStockIncentivePlansTables" id="DisclosureShareBasedCompensationStockIncentivePlansTables">
        <link:definition>31103 - Disclosure - Share-based Compensation Stock Incentive Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureOrganizationDetails" id="DisclosureOrganizationDetails">
        <link:definition>40101 - Disclosure - Organization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesOtherAccruedExpensesDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesOtherAccruedExpensesDetails">
        <link:definition>40203 - Disclosure - Summary of Significant Accounting Policies - Other Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesConvertiblePreferredStockDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesConvertiblePreferredStockDetails">
        <link:definition>40204 - Disclosure - Summary of Significant Accounting Policies - Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPotentiallyDilutiveSecuritiesOutstandingDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesPotentiallyDilutiveSecuritiesOutstandingDetails">
        <link:definition>40206 - Disclosure - Summary of Significant Accounting Policies - Potentially Dilutive Securities Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureForwardMergerNarrativesDetails" id="DisclosureForwardMergerNarrativesDetails">
        <link:definition>40301 - Disclosure - Forward Merger - Narratives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureForwardMergerAllocationOfPurchasePriceDetails" id="DisclosureForwardMergerAllocationOfPurchasePriceDetails">
        <link:definition>40303 - Disclosure - Forward Merger - Allocation of the purchase price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureForwardMergerNumberOfSharesOfCommonStockIssuedAndAmountsRecordedToArriveAtOpeningConsolidatedBalanceSheetOfSuccessorDetails" id="DisclosureForwardMergerNumberOfSharesOfCommonStockIssuedAndAmountsRecordedToArriveAtOpeningConsolidatedBalanceSheetOfSuccessorDetails">
        <link:definition>40304 - Disclosure - Forward Merger - Number of shares of common stock issued and amounts recorded to arrive at the opening consolidated balance sheet of the Successor (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureRelatedPartyTransactionsPredecessor2019DebtFinancingsDetails" id="DisclosureRelatedPartyTransactionsPredecessor2019DebtFinancingsDetails">
        <link:definition>40401 - Disclosure - Related Party Transactions (Predecessor) - 2019 Debt Financings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureRelatedPartyTransactionsPredecessorSchConvertibleNoteDetails" id="DisclosureRelatedPartyTransactionsPredecessorSchConvertibleNoteDetails">
        <link:definition>40402 - Disclosure - Related Party Transactions (Predecessor) - SCH Convertible Note (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureRelatedPartyTransactionsPredecessorA1ConvertibleNotesDetails" id="DisclosureRelatedPartyTransactionsPredecessorA1ConvertibleNotesDetails">
        <link:definition>40403 - Disclosure - Related Party Transactions (Predecessor) - A1 Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureRelatedPartyTransactionsPredecessorClarionUnwindFeeDetails" id="DisclosureRelatedPartyTransactionsPredecessorClarionUnwindFeeDetails">
        <link:definition>40404 - Disclosure - Related Party Transactions (Predecessor) - Clarion Unwind Fee (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureDaewoongConvertibleNotesPredecessorDetails" id="DisclosureDaewoongConvertibleNotesPredecessorDetails">
        <link:definition>40501 - Disclosure - Daewoong Convertible Notes (Predecessor) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsConvertibleNotesAtFairValueDetails" id="DisclosureFairValueMeasurementsConvertibleNotesAtFairValueDetails">
        <link:definition>40601 - Disclosure - Fair Value Measurements - Convertible Notes at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsForwardPurchaseAgreementsDetails" id="DisclosureFairValueMeasurementsForwardPurchaseAgreementsDetails">
        <link:definition>40603 - Disclosure - Fair Value Measurements - Forward Purchase Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsSignificantInputsAsOfValuationDatesDetails" id="DisclosureFairValueMeasurementsSignificantInputsAsOfValuationDatesDetails">
        <link:definition>40604 - Disclosure - Fair Value Measurements - Significant inputs as of the valuation dates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsNewMoneyPipeSubscriptionAgreementsAndLetterAgreementsWarrantsDetails" id="DisclosureFairValueMeasurementsNewMoneyPipeSubscriptionAgreementsAndLetterAgreementsWarrantsDetails">
        <link:definition>40605 - Disclosure - Fair Value Measurements - New Money PIPE Subscription Agreements and Letter Agreements, Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsContingentConsiderationAndContingentFounderSharesSuccessorDetails" id="DisclosureFairValueMeasurementsContingentConsiderationAndContingentFounderSharesSuccessorDetails">
        <link:definition>40606 - Disclosure - Fair Value Measurements - Contingent Consideration and Contingent Founder Shares (Successor) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsMedytoxTopOffRightDetails" id="DisclosureFairValueMeasurementsMedytoxTopOffRightDetails">
        <link:definition>40607 - Disclosure - Fair Value Measurements - Medytox Top-off Right (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsCommittedFinancingDetails" id="DisclosureFairValueMeasurementsCommittedFinancingDetails">
        <link:definition>40608 - Disclosure - Fair Value Measurements - Committed Financing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsCompanySRecurringMeasurementsForAssetsAndLiabilitiesAtFairValueDetails" id="DisclosureFairValueMeasurementsCompanySRecurringMeasurementsForAssetsAndLiabilitiesAtFairValueDetails">
        <link:definition>40609 - Disclosure - Fair Value Measurements - Company's recurring measurements for assets and liabilities at fair value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingenciesDaewoongLicenseAndSupplyAgreementDetails" id="DisclosureCommitmentsAndContingenciesDaewoongLicenseAndSupplyAgreementDetails">
        <link:definition>40704 - Disclosure - Commitments and Contingencies - Daewoong License and Supply Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingenciesMedytoxLitigationDetails" id="DisclosureCommitmentsAndContingenciesMedytoxLitigationDetails">
        <link:definition>40706 - Disclosure - Commitments and Contingencies - Medytox Litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureIncomeTaxesDetails" id="DisclosureIncomeTaxesDetails">
        <link:definition>40801 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureConvertiblePreferredStockTabularDetails" id="DisclosureConvertiblePreferredStockTabularDetails">
        <link:definition>40902 - Disclosure - Convertible Preferred Stock - Tabular (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureConvertiblePreferredStockVotingRightsElectionOfDirectorsDetails" id="DisclosureConvertiblePreferredStockVotingRightsElectionOfDirectorsDetails">
        <link:definition>40903 - Disclosure - Convertible Preferred Stock - Voting Rights, Election of Directors (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureConvertiblePreferredStockDividendsLiquidationAndConversionDetails" id="DisclosureConvertiblePreferredStockDividendsLiquidationAndConversionDetails">
        <link:definition>40904 - Disclosure - Convertible Preferred Stock - Dividends, Liquidation and Conversion (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureCommonStockDetails" id="DisclosureCommonStockDetails">
        <link:definition>41001 - Disclosure - Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureCommonStockCommonStockReservedForFutureIssuanceDetails" id="DisclosureCommonStockCommonStockReservedForFutureIssuanceDetails">
        <link:definition>41002 - Disclosure - Common Stock - Common stock reserved for future issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureShareBasedCompensationStockIncentivePlansStockIncentivePlansDetails" id="DisclosureShareBasedCompensationStockIncentivePlansStockIncentivePlansDetails">
        <link:definition>41101 - Disclosure - Share-based Compensation Stock Incentive Plans - Stock Incentive Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureShareBasedCompensationStockIncentivePlansShareBasedAwardActivityDetails" id="DisclosureShareBasedCompensationStockIncentivePlansShareBasedAwardActivityDetails">
        <link:definition>41102 - Disclosure - Share-based Compensation Stock Incentive Plans - Share-based Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureShareBasedCompensationStockIncentivePlansShareBasedCompensationExpenseAndValuationInformationDetails" id="DisclosureShareBasedCompensationStockIncentivePlansShareBasedCompensationExpenseAndValuationInformationDetails">
        <link:definition>41103 - Disclosure - Share-based Compensation Stock Incentive Plans - Share-based Compensation Expense and Valuation Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureSubsequentEventsDetails" id="DisclosureSubsequentEventsDetails">
        <link:definition>41201 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" id="StatementCondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureOrganization" id="DisclosureOrganization">
        <link:definition>10101 - Disclosure - Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies" id="DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>10201 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureForwardMerger" id="DisclosureForwardMerger">
        <link:definition>10301 - Disclosure - Forward Merger</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureRelatedPartyTransactionsPredecessor" id="DisclosureRelatedPartyTransactionsPredecessor">
        <link:definition>10401 - Disclosure - Related Party Transactions (Predecessor)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureDaewoongConvertibleNotesPredecessor" id="DisclosureDaewoongConvertibleNotesPredecessor">
        <link:definition>10501 - Disclosure - Daewoong Convertible Notes (Predecessor)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurements" id="DisclosureFairValueMeasurements">
        <link:definition>10601 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingencies" id="DisclosureCommitmentsAndContingencies">
        <link:definition>10701 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>10801 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureConvertiblePreferredStock" id="DisclosureConvertiblePreferredStock">
        <link:definition>10901 - Disclosure - Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureCommonStock" id="DisclosureCommonStock">
        <link:definition>11001 - Disclosure - Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureShareBasedCompensationStockIncentivePlans" id="DisclosureShareBasedCompensationStockIncentivePlans">
        <link:definition>11101 - Disclosure - Share-based Compensation Stock Incentive Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>11201 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>20202 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>30203 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureForwardMergerTables" id="DisclosureForwardMergerTables">
        <link:definition>30303 - Disclosure - Forward Merger (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingenciesTables" id="DisclosureCommitmentsAndContingenciesTables">
        <link:definition>30703 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureConvertiblePreferredStockTables" id="DisclosureConvertiblePreferredStockTables">
        <link:definition>30903 - Disclosure - Convertible Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureCommonStockTables" id="DisclosureCommonStockTables">
        <link:definition>31003 - Disclosure - Common Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails">
        <link:definition>40201 - Disclosure - Summary of Significant Accounting Policies - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesBasicAndDilutedNetLossPerShareDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesBasicAndDilutedNetLossPerShareDetails">
        <link:definition>40205 - Disclosure - Summary of Significant Accounting Policies - Basic And Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureFairValueMeasurementsPreferredStockWarrantLiabilityDetails" id="DisclosureFairValueMeasurementsPreferredStockWarrantLiabilityDetails">
        <link:definition>40602 - Disclosure - Fair Value Measurements - Preferred Stock Warrant Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingenciesSupplementalDisclosuresOfOperatingCostAndCashFlowInformationRelatedToOperatingLeasesDetails" id="DisclosureCommitmentsAndContingenciesSupplementalDisclosuresOfOperatingCostAndCashFlowInformationRelatedToOperatingLeasesDetails">
        <link:definition>40703 - Disclosure - Commitments and Contingencies - Supplemental disclosures of operating cost and cash flow information related to operating leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureCommitmentsAndContingenciesLegalProceedingsDetails" id="DisclosureCommitmentsAndContingenciesLegalProceedingsDetails">
        <link:definition>40705 - Disclosure - Commitments and Contingencies - Legal Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureConvertiblePreferredStockDetails" id="DisclosureConvertiblePreferredStockDetails">
        <link:definition>40901 - Disclosure - Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureConvertiblePreferredStockConvertiblePreferredStockWarrantsDetails" id="DisclosureConvertiblePreferredStockConvertiblePreferredStockWarrantsDetails">
        <link:definition>40905 - Disclosure - Convertible Preferred Stock - Convertible Preferred Stock Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="aeon-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aeon-20230930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aeon-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aeon-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://www.aeonbiopharma.com/role/DisclosureStandardAndCustomAxisDomainDefaults" id="DisclosureStandardAndCustomAxisDomainDefaults">
        <link:definition>99900 - Disclosure - Standard And Custom Axis Domain Defaults</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd" />
  <xsd:element name="AccruedClinicalTrailsExpensesCurrent" id="aeon_AccruedClinicalTrailsExpensesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ChangeInFairValueOfConvertibleNotes" id="aeon_ChangeInFairValueOfConvertibleNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="LossAndComprehensiveLoss" id="aeon_LossAndComprehensiveLoss" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="NonCashFinancingActivitiesAbstract" id="aeon_NonCashFinancingActivitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SharesAvailableForFutureIssuanceUnderStockIncentivePlanMember" id="aeon_SharesAvailableForFutureIssuanceUnderStockIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ConvertiblePreferredStockWarrantsMember" id="aeon_ConvertiblePreferredStockWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ScheduleOfCommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock" id="aeon_ScheduleOfCommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="TemporaryEquityDisclosureTextBlock" id="aeon_TemporaryEquityDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="LesseeOperatingLeaseSupplementalBalanceSheetInformationTableTextBlock" id="aeon_LesseeOperatingLeaseSupplementalBalanceSheetInformationTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DaewoongLicenseAndSupplyAgreementMember" id="aeon_DaewoongLicenseAndSupplyAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="AutomaticRenewalForUnlimitedAdditionalTerm" id="aeon_AutomaticRenewalForUnlimitedAdditionalTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="TerminationUponContinuingDefaultTerm" id="aeon_TerminationUponContinuingDefaultTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="TerminationUponPaymentDefaultTerm" id="aeon_TerminationUponPaymentDefaultTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="AmountAccruedRelatedToAgreement" id="aeon_AmountAccruedRelatedToAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="SeriesConvertiblePreferredStockMember" id="aeon_SeriesConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SeriesA1ConvertiblePreferredStockMember" id="aeon_SeriesA1ConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SeriesA2ConvertiblePreferredStockMember" id="aeon_SeriesA2ConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SeriesBConvertiblePreferredStockMember" id="aeon_SeriesBConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SeriesB1ConvertiblePreferredStockMember" id="aeon_SeriesB1ConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SeriesB2ConvertiblePreferredStockMember" id="aeon_SeriesB2ConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="NumberOfVotesForEachShareOfCommonStockIntoWhichPreferredStockCouldBeConverted" id="aeon_NumberOfVotesForEachShareOfCommonStockIntoWhichPreferredStockCouldBeConverted" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NumberOfDirectorToBeElectedByPreferredStockHolders" id="aeon_NumberOfDirectorToBeElectedByPreferredStockHolders" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="MinimumSalePriceOfCommonStockInUnderwrittenPublicOfferingForAutomaticConversionOfConvertiblePreferredStock" id="aeon_MinimumSalePriceOfCommonStockInUnderwrittenPublicOfferingForAutomaticConversionOfConvertiblePreferredStock" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="MinimumNetProceedsFromSaleOfCommonStockInUnderwrittenPublicOfferingForAutomaticConversionOfConvertiblePreferredStock" id="aeon_MinimumNetProceedsFromSaleOfCommonStockInUnderwrittenPublicOfferingForAutomaticConversionOfConvertiblePreferredStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="MinimumPercentageOfVotingForAutomaticConversionOfConvertiblePreferredStock" id="aeon_MinimumPercentageOfVotingForAutomaticConversionOfConvertiblePreferredStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PublicOfferingPricePerShareAsPercentageOfThenEffectivePerShare" id="aeon_PublicOfferingPricePerShareAsPercentageOfThenEffectivePerShare" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ConvertiblePreferredStockPolicyTextBlock" id="aeon_ConvertiblePreferredStockPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NoncontrollingInterestPolicyTextBlock" id="aeon_NoncontrollingInterestPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ConvertibleNotesIssuedOnIssuedOnAugust272020Member" id="aeon_ConvertibleNotesIssuedOnIssuedOnAugust272020Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ConvertibleNotesIssuedOnIssuedOnSeptember182020Member" id="aeon_ConvertibleNotesIssuedOnIssuedOnSeptember182020Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="DaewoongMember" id="aeon_DaewoongMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ConvertiblePromissoryNotePurchaseAgreementMember" id="aeon_ConvertiblePromissoryNotePurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="AmendedConvertiblePromissoryNotePurchaseAgreementMember" id="aeon_AmendedConvertiblePromissoryNotePurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="NumberOfPromissoryNotesIssued" id="aeon_NumberOfPromissoryNotesIssued" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DebtInstrumentConvertedDenominatorUsedToCalculateForNumberOfSharesIssuableUponConversion" id="aeon_DebtInstrumentConvertedDenominatorUsedToCalculateForNumberOfSharesIssuableUponConversion" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="DebtInstrumentConvertedPercentageMultipliedCalculatedOnCommonStockOutstanding" id="aeon_DebtInstrumentConvertedPercentageMultipliedCalculatedOnCommonStockOutstanding" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DebtInstrumentConvertedAggregateValueOfSharesImmediatelyPriorToIpo" id="aeon_DebtInstrumentConvertedAggregateValueOfSharesImmediatelyPriorToIpo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="MinimumPercentageOfOwnershipInterestPreIpoAfterConversionOfDebtInstrument" id="aeon_MinimumPercentageOfOwnershipInterestPreIpoAfterConversionOfDebtInstrument" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="MinimumPreMoneyValuationAtTimeOfSharesSoldInIpo" id="aeon_MinimumPreMoneyValuationAtTimeOfSharesSoldInIpo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ThresholdBusinessDaysForPreMoneyValuationAfterConversionOfNotes" id="aeon_ThresholdBusinessDaysForPreMoneyValuationAfterConversionOfNotes" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="Aeon2013StockIncentivePlanMember" id="aeon_Aeon2013StockIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="AbpSubInc.2019IncentiveAwardPlanMember" id="aeon_AbpSubInc.2019IncentiveAwardPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="StockOptionsGrantedTo10StockholderMember" id="aeon_StockOptionsGrantedTo10StockholderMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="MinimumShareholdingAsPercentageOfTotalCombinedVotingPowerOfAllClassesOfStockOfCompany" id="aeon_MinimumShareholdingAsPercentageOfTotalCombinedVotingPowerOfAllClassesOfStockOfCompany" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ExercisePriceOfOptionsAsPercentageOfEstimatedFairValueOfCompanysCommonStockMaximum" id="aeon_ExercisePriceOfOptionsAsPercentageOfEstimatedFairValueOfCompanysCommonStockMaximum" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DentalInnovationsMember" id="aeon_DentalInnovationsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="StrathspeyCrownHoldingsGroupLlcMember" id="aeon_StrathspeyCrownHoldingsGroupLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="Original2019NotePurchaseAgreementMember" id="aeon_Original2019NotePurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="AdditionalPromissoryNoteMember" id="aeon_AdditionalPromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SimhambhatlaMember" id="aeon_SimhambhatlaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="JaywinMember" id="aeon_JaywinMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="WillisMember" id="aeon_WillisMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="MalikMember" id="aeon_MalikMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ConvertibleNotes2019Member" id="aeon_ConvertibleNotes2019Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="NumberOfAdditionalConvertiblePromissoryNotesSold" id="aeon_NumberOfAdditionalConvertiblePromissoryNotesSold" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PercentageOfRepaymentOfPrincipalAmount" id="aeon_PercentageOfRepaymentOfPrincipalAmount" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PercentageOfConvertibleNotesConvertIntoNumberOfSharesOfCommonStock" id="aeon_PercentageOfConvertibleNotesConvertIntoNumberOfSharesOfCommonStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="IncomeExpenseRelatedToDecreaseIncreaseInFairValueOfConvertibleNotes" id="aeon_IncomeExpenseRelatedToDecreaseIncreaseInFairValueOfConvertibleNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ConvertibleNotesAdditionalAmountRepayableToPrincipalAmount" id="aeon_ConvertibleNotesAdditionalAmountRepayableToPrincipalAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="SchConvertibleNoteMember" id="aeon_SchConvertibleNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="Alphaeon1LlcMember" id="aeon_Alphaeon1LlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="A1PurchaseAgreementMember" id="aeon_A1PurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="A1ConvertibleNotesMember" id="aeon_A1ConvertibleNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="A1ConvertibleNotes2021Member" id="aeon_A1ConvertibleNotes2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="A1ConvertibleNotesIssuedOn8thDecember2021Member" id="aeon_A1ConvertibleNotesIssuedOn8thDecember2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="A1ConvertibleNotesIssuedOn15thDecember2021Member" id="aeon_A1ConvertibleNotesIssuedOn15thDecember2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="A1ConvertibleNotes2022Member" id="aeon_A1ConvertibleNotes2022Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="A1ConvertibleNotesIssuedOn18thFebruary2022Member" id="aeon_A1ConvertibleNotesIssuedOn18thFebruary2022Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="A1ConvertibleNotesIssuedOn9thMarch2022Member" id="aeon_A1ConvertibleNotesIssuedOn9thMarch2022Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="A1ConvertibleNotesIssuedOn14thApril2022Member" id="aeon_A1ConvertibleNotesIssuedOn14thApril2022Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="A1ConvertibleNotesIssuedOn1stJuly2022Member" id="aeon_A1ConvertibleNotesIssuedOn1stJuly2022Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="NumberOfConvertibleNotesIssued" id="aeon_NumberOfConvertibleNotesIssued" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PercentageOfDiscountRateIfNumberOfDaysBetweenExecutionDateAndConversionDateAreBetweenZeroAnd90" id="aeon_PercentageOfDiscountRateIfNumberOfDaysBetweenExecutionDateAndConversionDateAreBetweenZeroAnd90" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PercentageOfDiscountRateIfNumberOfDaysBetweenExecutionDateAndConversionDateAreBetween91And180" id="aeon_PercentageOfDiscountRateIfNumberOfDaysBetweenExecutionDateAndConversionDateAreBetween91And180" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PercentageOfDiscountRateIfNumberOfDaysBetweenExecutionDateAndConversionDateIsGreaterThan180" id="aeon_PercentageOfDiscountRateIfNumberOfDaysBetweenExecutionDateAndConversionDateIsGreaterThan180" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NumberOfAdditionalTranchesOfSubordinatedConvertiblePromissoryNotesIssued" id="aeon_NumberOfAdditionalTranchesOfSubordinatedConvertiblePromissoryNotesIssued" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="IncreaseDecreaseInAccruedExpensesAndOtherLiabilities" id="aeon_IncreaseDecreaseInAccruedExpensesAndOtherLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="A1ConvertibleNotesIssuedOnJune32022Member" id="aeon_A1ConvertibleNotesIssuedOnJune32022Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="StrathspeyCrownNote2020Member" id="aeon_StrathspeyCrownNote2020Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="A1ConvertibleNotes2023Member" id="aeon_A1ConvertibleNotes2023Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ForwardPurchaseAgreementMember" id="aeon_ForwardPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="StockholdersEquityPeriodIncreaseDecreaseThroughDebitExtinguishmentDueToWarrantModification" id="aeon_StockholdersEquityPeriodIncreaseDecreaseThroughDebitExtinguishmentDueToWarrantModification" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="A1ConvertibleNotesMarch2023Member" id="aeon_A1ConvertibleNotesMarch2023Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ChangesInFairValueOfConvertibleNotes" id="aeon_ChangesInFairValueOfConvertibleNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="SubscriptionReceivablesMember" id="aeon_SubscriptionReceivablesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="AeonBiopharmaInc2023IncentiveAwardPlanMember" id="aeon_AeonBiopharmaInc2023IncentiveAwardPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ForwardPurchaseAgreementAndDerivativeLiability" id="aeon_ForwardPurchaseAgreementAndDerivativeLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ChangeInFairValueOfForwardPurchaseAgreementAndDerivative" id="aeon_ChangeInFairValueOfForwardPurchaseAgreementAndDerivative" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="DeferredUnderwritingFee" id="aeon_DeferredUnderwritingFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="OtherAccruedExpensesPolicyPolicyTextBlock" id="aeon_OtherAccruedExpensesPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="UnauditedInterimFinancialInformationPolicyPolicyTextBlock" id="aeon_UnauditedInterimFinancialInformationPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ThirdPartyUsageLiabilitiesCurrent" id="aeon_ThirdPartyUsageLiabilitiesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="RemainingOtherAccruedLiabilities" id="aeon_RemainingOtherAccruedLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ContingentConsiderationPolicyPolicyTextBlock" id="aeon_ContingentConsiderationPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="WarrantsPolicyPolicyTextBlock" id="aeon_WarrantsPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ContingentConsiderationMember" id="aeon_ContingentConsiderationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CommonStockOptionsAndRestrictedStockUnitsMember" id="aeon_CommonStockOptionsAndRestrictedStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="PercentageOfSharesHoldersReceiveViaPreviousWarrantAgreement" id="aeon_PercentageOfSharesHoldersReceiveViaPreviousWarrantAgreement" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ContingentConsiderationLiability" id="aeon_ContingentConsiderationLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="ChangeInAmountOfContingentConsiderationLiability" id="aeon_ChangeInAmountOfContingentConsiderationLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="AcquiredInProcessResearchAndDevelopmentExpense" id="aeon_AcquiredInProcessResearchAndDevelopmentExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="IntangibleAssetsOfOldAeonAcquiredMember" id="aeon_IntangibleAssetsOfOldAeonAcquiredMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="PriveterraMember" id="aeon_PriveterraMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="AdditionalCommittedFinancingAgreementWithA1Member" id="aeon_AdditionalCommittedFinancingAgreementWithA1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="FounderSharesMember" id="aeon_FounderSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ContingentFounderSharesMember" id="aeon_ContingentFounderSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="NumberOfSharesToBeReceivedPriorToMerger" id="aeon_NumberOfSharesToBeReceivedPriorToMerger" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="NumberOfFounderSharesSubjectToVestingAndForfeiture" id="aeon_NumberOfFounderSharesSubjectToVestingAndForfeiture" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="FairValueOfReplacementAwardsIncludedInPurchaseConsideration" id="aeon_FairValueOfReplacementAwardsIncludedInPurchaseConsideration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="AssetAcquisitionPercentageOfVotingInterestsAcquired" id="aeon_AssetAcquisitionPercentageOfVotingInterestsAcquired" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NetWorkingCapitalExcludingCash" id="aeon_NetWorkingCapitalExcludingCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="OtherAssetsAndLiabilitiesNet" id="aeon_OtherAssetsAndLiabilitiesNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ScheduleOfAllocationOfPurchasePriceTableTextBlock" id="aeon_ScheduleOfAllocationOfPurchasePriceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PriveterraAndOldAeonMember" id="aeon_PriveterraAndOldAeonMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="Alphaeon1LlcAndDaewoongPharmaceuticalsCoLtdMember" id="aeon_Alphaeon1LlcAndDaewoongPharmaceuticalsCoLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ConversionOfConvertiblePreferredStockMember" id="aeon_ConversionOfConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ContingentConsiderationSharesMember" id="aeon_ContingentConsiderationSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="WarrantsMember" id="aeon_WarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ReductionInFairValueNotesDueToWarrantModification" id="aeon_ReductionInFairValueNotesDueToWarrantModification" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod" id="aeon_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice" id="aeon_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ConversionRatioOfOptionsAndRsuAwardsThatWereOutstandingImmediatelyPriorToMergerToCommonStock" id="aeon_ConversionRatioOfOptionsAndRsuAwardsThatWereOutstandingImmediatelyPriorToMergerToCommonStock" type="xbrli:pureItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="OptionsGrantedToPurchaseNumberOfSubOptions" id="aeon_OptionsGrantedToPurchaseNumberOfSubOptions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="OptionsToPurchaseNumberOfSharesOfCommonStock" id="aeon_OptionsToPurchaseNumberOfSharesOfCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="OptionsToPurchaseNumberOfRestrictedStockUnitsAwards" id="aeon_OptionsToPurchaseNumberOfRestrictedStockUnitsAwards" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="RestrictedStockUnitAwardsCoveringNumberOfSharesOfCommonStock" id="aeon_RestrictedStockUnitAwardsCoveringNumberOfSharesOfCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" id="aeon_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantDateFairValue" id="aeon_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantDateFairValue" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfSharesAvailableForIssuance" id="aeon_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualIncreaseOfSharesAvailableForIssuance" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="StockToBeIssuedDuringPeriodShares" id="aeon_StockToBeIssuedDuringPeriodShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NumberOfSharesPurchasedBySellerFromThirdPartiesThroughBrokerInOpenMarket" id="aeon_NumberOfSharesPurchasedBySellerFromThirdPartiesThroughBrokerInOpenMarket" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PercentageOfMaximumAllowedSellerSOwnership" id="aeon_PercentageOfMaximumAllowedSellerSOwnership" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PrepaymentAmountToBePaidToSeller" id="aeon_PrepaymentAmountToBePaidToSeller" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="debit" />
  <xsd:element name="NumberOfAdditionalSharesToBeIssued" id="aeon_NumberOfAdditionalSharesToBeIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="RedemptionPricePerShare" id="aeon_RedemptionPricePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PresentValueOfPrepaymentAmount" id="aeon_PresentValueOfPrepaymentAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
  <xsd:element name="LossOnIssuanceOfFinancingArrangements" id="aeon_LossOnIssuanceOfFinancingArrangements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="ResetPriceFloor" id="aeon_ResetPriceFloor" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="MaximumNumberOfSharesOfCommonStockToBeIssuedOnCashSettlementPaymentDate" id="aeon_MaximumNumberOfSharesOfCommonStockToBeIssuedOnCashSettlementPaymentDate" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PricePerShareOnCashSettlementPaymentDate" id="aeon_PricePerShareOnCashSettlementPaymentDate" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PrivatePlacementWarrantsMember" id="aeon_PrivatePlacementWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="WarrantLiabilitiesMember" id="aeon_WarrantLiabilitiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="PublicWarrantsMember" id="aeon_PublicWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="IfClosingPriceOfCommonStockEqualsOrExceeds18.00PerShareMember" id="aeon_IfClosingPriceOfCommonStockEqualsOrExceeds18.00PerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="IfClosingPriceOfCommonStockEqualsOrExceeds10.00PerShareMember" id="aeon_IfClosingPriceOfCommonStockEqualsOrExceeds10.00PerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ClassOfWarrantOrRightExercisableTerm" id="aeon_ClassOfWarrantOrRightExercisableTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ClassOfWarrantOrRightRedemptionTerm" id="aeon_ClassOfWarrantOrRightRedemptionTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ClassOfWarrantOrRightRedemptionPrice" id="aeon_ClassOfWarrantOrRightRedemptionPrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" id="aeon_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" id="aeon_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ClassOfWarrantOrRightNumberOfBusinessDaysBeforeEntitySendsNoticeOfRedemptionConsideredForTradingPeriodTerm" id="aeon_ClassOfWarrantOrRightNumberOfBusinessDaysBeforeEntitySendsNoticeOfRedemptionConsideredForTradingPeriodTerm" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ClassOfWarrantOrRightNumberOfWarrantsIssued" id="aeon_ClassOfWarrantOrRightNumberOfWarrantsIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NewMoneyPipeSubscriptionAgreementsMember" id="aeon_NewMoneyPipeSubscriptionAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="LetterAgreementsMember" id="aeon_LetterAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SponsorMember" id="aeon_SponsorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="NumberOfSharesToBeTransferredBySponsor" id="aeon_NumberOfSharesToBeTransferredBySponsor" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ThresholdBusinessDaysForTransferOfShares" id="aeon_ThresholdBusinessDaysForTransferOfShares" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ThresholdConsecutiveTradingDaysEndingOnTradingDayImmediatelyPriorToMeasurementDate" id="aeon_ThresholdConsecutiveTradingDaysEndingOnTradingDayImmediatelyPriorToMeasurementDate" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NumberOfAwardsContainedVestingCriteria" id="aeon_NumberOfAwardsContainedVestingCriteria" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="MigrainePhase3ContingentFounderSharesMember" id="aeon_MigrainePhase3ContingentFounderSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="CdBlaContingentFounderSharesMember" id="aeon_CdBlaContingentFounderSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="EpisodicChronicMigraineContingentFounderSharesMember" id="aeon_EpisodicChronicMigraineContingentFounderSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="EpisodicMigraineContingentConsiderationSharesMember" id="aeon_EpisodicMigraineContingentConsiderationSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ChronicMigraineContingentConsiderationSharesMember" id="aeon_ChronicMigraineContingentConsiderationSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="UponAchievementOfConditionsForIssuanceOfMigrainePhase3ContingentConsiderationSharesOnOrPriorToMigrainePhase3OutsideDateMember" id="aeon_UponAchievementOfConditionsForIssuanceOfMigrainePhase3ContingentConsiderationSharesOnOrPriorToMigrainePhase3OutsideDateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="UponAchievementOfConditionsForIssuanceOfCdBlaContingentConsiderationSharesOnOrPriorToCdBlaOutsideDateMember" id="aeon_UponAchievementOfConditionsForIssuanceOfCdBlaContingentConsiderationSharesOnOrPriorToCdBlaOutsideDateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="UponEarlierOfIssuanceOfEpisodicMigraineSharesOnOrBeforeEpisodicMigraineOutsideDateAndChronicMigraineSharesOnOrBeforeChronicMigraineOutsideDateMember" id="aeon_UponEarlierOfIssuanceOfEpisodicMigraineSharesOnOrBeforeEpisodicMigraineOutsideDateAndChronicMigraineSharesOnOrBeforeChronicMigraineOutsideDateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="PercentageOfSharesUnvestedAndSubjectToRestrictionsAndForfeitureProvisions" id="aeon_PercentageOfSharesUnvestedAndSubjectToRestrictionsAndForfeitureProvisions" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PercentageOfSharesNotSubjectToRestrictionsAndForfeitureProvisions" id="aeon_PercentageOfSharesNotSubjectToRestrictionsAndForfeitureProvisions" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PercentageOfWarrantsNotSubjectToRestrictionsAndForfeitureProvisions" id="aeon_PercentageOfWarrantsNotSubjectToRestrictionsAndForfeitureProvisions" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ThresholdIncreaseInEpisodicMigraineContingentConsiderationShares" id="aeon_ThresholdIncreaseInEpisodicMigraineContingentConsiderationShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NumberOfChronicMigraineContingentConsiderationSharesByIncreaseInEpisodicMigraineContingentConsiderationShares" id="aeon_NumberOfChronicMigraineContingentConsiderationSharesByIncreaseInEpisodicMigraineContingentConsiderationShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NumberOfContingentConsiderationSharesToBeIssuedUponThresholdIncreaseInEpisodicMigraineContingentConsiderationShares" id="aeon_NumberOfContingentConsiderationSharesToBeIssuedUponThresholdIncreaseInEpisodicMigraineContingentConsiderationShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="NumberOfSharesBecomeDueAndPayableIfProductLicensesGivenBeforeSatisfactionOfIssuanceOfContingentShares" id="aeon_NumberOfSharesBecomeDueAndPayableIfProductLicensesGivenBeforeSatisfactionOfIssuanceOfContingentShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ReductionInNumberOfEpisodicMigraineContingentConsiderationSharesIfProductLicensesGivenBeforeSatisfactionOfIssuanceOfShares" id="aeon_ReductionInNumberOfEpisodicMigraineContingentConsiderationSharesIfProductLicensesGivenBeforeSatisfactionOfIssuanceOfShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ReductionInNumberOfChronicMigraineContingentConsiderationSharesIfProductLicensesGivenBeforeSatisfactionOfIssuanceOfShares" id="aeon_ReductionInNumberOfChronicMigraineContingentConsiderationSharesIfProductLicensesGivenBeforeSatisfactionOfIssuanceOfShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="MinimumNumberOfChronicMigraineContingentConsiderationSharesAfterReduction" id="aeon_MinimumNumberOfChronicMigraineContingentConsiderationSharesAfterReduction" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="CommittedFinancingAgreementsMember" id="aeon_CommittedFinancingAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="StockCompensationForConversionOfFounderSharesIntoCommonSharesValue" id="aeon_StockCompensationForConversionOfFounderSharesIntoCommonSharesValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="StockCompensationForConversionOfFounderSharesIntoCommonSharesShares" id="aeon_StockCompensationForConversionOfFounderSharesIntoCommonSharesShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="StockIssuedDuringPeriodValueForwardPurchaseAgreements" id="aeon_StockIssuedDuringPeriodValueForwardPurchaseAgreements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="StockIssuedDuringPeriodSharesForwardPurchaseAgreements" id="aeon_StockIssuedDuringPeriodSharesForwardPurchaseAgreements" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="IssuanceOfMakeWholeDerivativeAmount" id="aeon_IssuanceOfMakeWholeDerivativeAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="AdjustmentsToAdditionalPaidInCapitalFounderContingentShares" id="aeon_AdjustmentsToAdditionalPaidInCapitalFounderContingentShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="AdjustmentsForAcquiredInProcessResearchAndDevelopmentAndLossOnConsolidationOfVariableInterestEntity" id="aeon_AdjustmentsForAcquiredInProcessResearchAndDevelopmentAndLossOnConsolidationOfVariableInterestEntity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="AdjustmentsToAdditionalPaidInCapitalSettlementOfDerivative" id="aeon_AdjustmentsToAdditionalPaidInCapitalSettlementOfDerivative" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="DisclosureOfNumberOfSharesOfCommonStockIssuedAndAmountsRecordedOnLineToArriveAtOpeningConsolidatedBalanceSheetOfSuccessorTableTextBlock" id="aeon_DisclosureOfNumberOfSharesOfCommonStockIssuedAndAmountsRecordedOnLineToArriveAtOpeningConsolidatedBalanceSheetOfSuccessorTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PercentageOfSharesSubjectToVestingAndForfeitureConditions" id="aeon_PercentageOfSharesSubjectToVestingAndForfeitureConditions" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="RemainingSharesWithoutVestingConditions" id="aeon_RemainingSharesWithoutVestingConditions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="GranteDateFairValueOfRemainingSharesWithoutVestingConditionsExpensed" id="aeon_GranteDateFairValueOfRemainingSharesWithoutVestingConditionsExpensed" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="debit" />
  <xsd:element name="SettlementAgreementWithMedytoxMember" id="aeon_SettlementAgreementWithMedytoxMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="ThresholdTargetOwnershipPercentage" id="aeon_ThresholdTargetOwnershipPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="OldAeonCommonStockMember" id="aeon_OldAeonCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="GainLossOnIssuanceOfCommonShares" id="aeon_GainLossOnIssuanceOfCommonShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" xbrli:balance="credit" />
  <xsd:element name="DiscountRateUsedInDeterminingValueOfAcquiredInProcessResearchAndDevelopment" id="aeon_DiscountRateUsedInDeterminingValueOfAcquiredInProcessResearchAndDevelopment" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ImpliedInternalRateUsedInDeterminingValueOfAcquiredInProcessResearchAndDevelopment" id="aeon_ImpliedInternalRateUsedInDeterminingValueOfAcquiredInProcessResearchAndDevelopment" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="LongTermGrowthRateUsedInDeterminingValueOfAcquiredInProcessResearchAndDevelopment" id="aeon_LongTermGrowthRateUsedInDeterminingValueOfAcquiredInProcessResearchAndDevelopment" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="AssetAcquisitionAdditionalNumberOfSharesIssuable" id="aeon_AssetAcquisitionAdditionalNumberOfSharesIssuable" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" />
  <xsd:element name="PeriodAfterClosingResetPriceBecameSubjectToMonthlyResets" id="aeon_PeriodAfterClosingResetPriceBecameSubjectToMonthlyResets" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PurchaseAgreementsVolumeWeightedAveragePeriod" id="aeon_PurchaseAgreementsVolumeWeightedAveragePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ResetPrice" id="aeon_ResetPrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ValuationDatePeriodAfterClosingDateOfBusinessCombinationAgreement" id="aeon_ValuationDatePeriodAfterClosingDateOfBusinessCombinationAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="ValuationDatePeriodAfterDeliveryOfWrittenNotice" id="aeon_ValuationDatePeriodAfterDeliveryOfWrittenNotice" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PurchaseAgreementConsecutiveTradingDays" id="aeon_PurchaseAgreementConsecutiveTradingDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="DilutiveOfferingThresholdSharePrice" id="aeon_DilutiveOfferingThresholdSharePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="false" />
  <xsd:element name="PredecessorPeriodJuly12023ToJuly212023Member" id="aeon_PredecessorPeriodJuly12023ToJuly212023Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="PredecessorPeriodJanuary12023ToJuly212023Member" id="aeon_PredecessorPeriodJanuary12023ToJuly212023Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SuccessorPeriodJuly222023ToSeptember302023Member" id="aeon_SuccessorPeriodJuly222023ToSeptember302023Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="PredecessorMember" id="aeon_PredecessorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SuccessorMember" id="aeon_SuccessorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" abstract="true" />
  <xsd:element name="SubscriptionReceivables" id="aeon_SubscriptionReceivables" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant" abstract="false" xbrli:balance="credit" />
</xsd:schema>
